To reach our long-term business objective of becoming one of the top biopharmaceutical companies in the world, Actelion adheres to four strategic principles:

1. Follow innovation where it leads
2. Retain the value of innovation
3. Excel in sales and marketing
4. Drive core values together

The key components of Actelion's strategy are:

1. Build our existing businesses in PAH and lipid storage disorders while developing or licensing additional synergetic products.

2. Pursue an R&D-focused growth strategy by pursuing internal projects, especially those which would accelerate value creation. Selectively form partnerships for these products to minimize risk, and optimize investment and return.

3. Seek licensing deals or acquisitions that are synergetic to existing businesses or to provide an infrastructure platform for pipeline products.

4. Focus on people: It takes professionals from many areas of expertise, working together over a sustained period of time, to create an innovative medicine. We know that products don’t discover or sell themselves and so we continue to grow our innovative team of creative minds.